Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine · Immunogenicity: Adequate antibody response (NT ≥1:10),
  Yellow fever vaccine for patients with HIV infection 2014 · Cochrane Headline outcomes only
  RR 0.86 [0.77, 0.96]
  1 study · 144 participants
  Very low
Direct match · question page
- Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine · Duration: Adequate antibody response (NT ≥1:10),
  Yellow fever vaccine for patients with HIV infection 2014 · Cochrane Headline outcomes only
  RR 0.88 [0.76, 1.02]
  1 study · 162 participants
  Very low
Related · question page
- Immunologic response to YF vaccine in HIV‐infected adults before HIV diagnosis, vs immunologic response to YF vaccine · Immunogenicity: Adequate antibody response (NT ≥1:10),
  Yellow fever vaccine for patients with HIV infection 2014 · Cochrane Headline outcomes only
  RR 0.91 [0.85, 0.98]
  1 study · 364 participants
  Low

Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine

Immunogenicity: Adequate antibody response (NT ≥1:10), · adults with HIV infection

It is very uncertain whether immunologic response to YF vaccine in HIV‐infected adults changes immunogenicity: Adequate antibody response (NT ≥1:10), compared with immunologic response to YF vaccine (very low certainty).

1 finding from 1 review

Yellow fever vaccine for patients with HIV infection 2014 · Cochrane Headline outcomes only
RR 0.86 [0.77, 0.96]
1 study · 144 participants
Very low

Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine

Duration: Adequate antibody response (NT ≥1:10), · adults with HIV infection

It is very uncertain whether immunologic response to YF vaccine in HIV‐infected adults changes duration: Adequate antibody response (NT ≥1:10), compared with immunologic response to YF vaccine (very low certainty).

1 finding from 1 review

Yellow fever vaccine for patients with HIV infection 2014 · Cochrane Headline outcomes only
RR 0.88 [0.76, 1.02]
1 study · 162 participants
Very low

Immunologic response to YF vaccine in HIV‐infected adults before HIV diagnosis, vs immunologic response to YF vaccine

Immunogenicity: Adequate antibody response (NT ≥1:10), · adults with HIV infection

Immunologic response to YF vaccine in HIV‐infected adults before HIV… may leads to lower immunogenicity: Adequate antibody response (NT ≥1:10), compared with immunologic response to YF vaccine (low certainty).

1 finding from 1 review

Yellow fever vaccine for patients with HIV infection 2014 · Cochrane Headline outcomes only
RR 0.91 [0.85, 0.98]
1 study · 364 participants
Low